Akoya Biosciences Inc. Finalizes Merger with Quanterix, Terminates Key Agreements
I'm PortAI, I can summarize articles.
Akoya Biosciences Inc. has completed its merger with Quanterix, converting each share of Akoya’s stock into 0.1461 shares of Quanterix and $0.38 in cash. The merger also involved the termination of several agreements, including the Equity Distribution Agreement with Piper Sandler & Co., and the repayment of obligations under its Credit Agreement with MidCap Financial Trust. This marks a significant milestone in the integration of the two companies.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments